Nursing Personnel in the Era of Personalized Healthcare in Clinical Practice

被引:14
作者
Spanakis, Marios [1 ,2 ]
Patelarou, Athina E. [2 ]
Patelarou, Evridiki [2 ]
机构
[1] Fdn Res & Technol Hellas FORTH, Inst Comp Sci, Computat BioMed Lab, GR-70013 Iraklion, Crete, Greece
[2] Hellen Mediterranean Univ, Fac Hlth Sci, Dept Nursing, GR-71004 Iraklion, Crete, Greece
来源
JOURNAL OF PERSONALIZED MEDICINE | 2020年 / 10卷 / 03期
关键词
personalized medicine; stratified medicine; precision health; personalized nursing care; evidence-based practice; EVIDENCE-BASED MEDICINE; PRECISION MEDICINE; STRATIFIED MEDICINE; DOSAGE ADJUSTMENT; NEXT-GENERATION; PHARMACOKINETICS; PHARMACOGENETICS; BIOMARKERS; CYTOCHROME-P450; PHARMACOLOGY;
D O I
10.3390/jpm10030056
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Personalized, stratified, or precision medicine (PM) introduces a new era in healthcare that tries to identify and predict optimum treatment outcomes for a patient or a cohort. It also introduces new scientific terminologies regarding therapeutic approaches and the need of their adoption from healthcare providers. Till today, evidence-based practice (EBP) was focusing on population averages and their variances among cohorts for clinical values that are essential for optimizing healthcare outcome. It can be stated that EBP and PM are complementary approaches for a modern healthcare system. Healthcare providers through EBP often see the forest (population averages) but miss the trees (individual patients), whereas utilization of PM may not see the forest for the trees. Nursing personnel (NP) play an important role in modern healthcare since they are consulting, educating, and providing care to patients whose needs often needs to be individualized (personalized nursing care, PNC). Based on the clinical issues earlier addressed from clinical pharmacology, EBP, and now encompassed in PM, this review tries to describe the challenges that NP have to face in order to meet the requisites of the new era in healthcare. It presents the demands that should be met for upgrading the provided education and expertise of NP toward an updated role in a modern healthcare system.
引用
收藏
页码:1 / 19
页数:16
相关论文
共 96 条
[1]   Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population [J].
Abduljalil, Khaled ;
Pan, Xian ;
Pansari, Amita ;
Jamei, Masoud ;
Johnson, Trevor N. .
CLINICAL PHARMACOKINETICS, 2020, 59 (04) :501-518
[2]  
[Anonymous], 2019, Boletim Epidemiologico, V50, P1, DOI DOI 10.1097/01.NUMA.0000552872.75154.83
[4]   Pharmacokinetics and Pharmacodynamics of Drugs Commonly Used in Pregnancy and Parturition [J].
Ansari, Jessica ;
Carvalho, Brendan ;
Shafer, Steven L. ;
Flood, Pamela .
ANESTHESIA AND ANALGESIA, 2016, 122 (03) :786-804
[5]   What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists [J].
Aronson, Jeffrey K. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) :161-169
[6]   The Precision Medicine Initiative A New National Effort [J].
Ashley, Euan A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (21) :2119-2120
[7]   Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities [J].
Beckmann, Jacques S. ;
Lew, Daniel .
GENOME MEDICINE, 2016, 8
[8]   Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications [J].
Bhattaram, VA ;
Booth, BP ;
Ramchandani, RP ;
Beasley, BN ;
Wang, YN ;
Tandon, V ;
Duan, JZ ;
Baweja, RK ;
Marroum, PJ ;
Uppoor, RS ;
Rahman, NA ;
Sahajwalla, CG ;
Powell, JR ;
Mehta, MU ;
Gobburu, JVS .
AAPS JOURNAL, 2005, 7 (03) :E503-E512
[9]   Clinical drug trials in general practice: how well are external validity issues reported? [J].
Braend, Anja Maria ;
Straand, Jorund ;
Klovning, Atle .
BMC FAMILY PRACTICE, 2017, 18
[10]   What if we made stratified medicine work for patients? [J].
Britten, Nicky ;
Pope, Catherine ;
Halford, Susan ;
Richeldi, Luca .
LANCET RESPIRATORY MEDICINE, 2016, 4 (01) :8-10